Macrophage membrane-camouflaged citrate-modified prussian blue nanozymes

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Animals1

Outcomes

3

Depressive-like behaviors

upin mice1

1 study
  1. Macrophage membrane-camouflaged citrate-modified prussian blue nanozymes improve depressive-like behaviors in mice.

    “effectively ameliorating bone loss, motor dysfunction, and depressive-like behaviors”

    Animalsin vivo

    Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation

    Journal of nanobiotechnologyJul 17, 2026

Motor dysfunction

downin mice1

1 study
  1. Macrophage membrane-camouflaged citrate-modified prussian blue nanozymes decrease motor dysfunction in mice.

    “effectively ameliorating bone loss, motor dysfunction, and depressive-like behaviors”

    Animalsin vivo

    Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation

    Journal of nanobiotechnologyJul 17, 2026

Bone volume/tissue volume ratio

upin mice1

1 study
  1. Macrophage membrane-camouflaged citrate-modified prussian blue nanozymes increase bone volume/tissue volume ratio in mice (3.83-fold).

    “In vivo, M@CPB increased bone volume/tissue volume ratio by 3.83-fold relative to SOP mice”

    Animalsrelative to SOP mice

    Membrane-coated Prussian blue nanocomplex with enhanced enzyme-mimic activity alleviates senile osteoporosis by reducing osteoprogenitor cell senescence and macrophage inflammation

    Journal of nanobiotechnologyJul 17, 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months